Ernesto De Menis < Erwan Bezard < Erwan Bézard

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 38.
[0-20] [0 - 20][0 - 38][20-37][20-40]

Ident.	Authors (with country if any)	Title
000000 (2017-01-10)	Daniel Ysselstein [Danemark] ; Benjamin Dehay [France] ; Isabel M. Costantino [États-Unis] ; Matthew P. Frosch [États-Unis] ; Julia M. George [Royaume-Uni] ; Erwan Bezard [France] ; Jean-Christophe Rochet [Danemark] ; Georges Mccabe [États-Unis]	Endosulfine-alpha inhibits membrane-induced α-synuclein aggregation and protects against α-synuclein neurotoxicity.
000012 (2016-11)	Anna Migdalska-Richards [Royaume-Uni] ; Liam Daly [Royaume-Uni] ; Erwan Bezard [France] ; Anthony H V. Schapira [Royaume-Uni]	Ambroxol effects in glucocerebrosidase and α-synuclein transgenic mice.
000015 (2016-07-13)	Wai Kin D. Ko [Royaume-Uni] ; Sandrine M. Camus [Royaume-Uni] ; Qin Li [Royaume-Uni] ; Yang Jianzhong [Royaume-Uni] ; Steve Mcguire [Royaume-Uni] ; Elsa Y. Pioli [Royaume-Uni] ; Erwan Bezard [Royaume-Uni]	An evaluation of istradefylline treatment on Parkinsonian motor and cognitive deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated macaque models.
000016 (2016-02)	Mathieu Bourdenx [France] ; Sandra Dovero [France] ; Philippe De Deurwaerdère [France] ; Qin Li [République populaire de Chine] ; Erwan Bezard [Royaume-Uni]	Early prenatal exposure to MPTP does not affect nigrostrial neurons in macaque monkey
000017 (2016-01-21)	Thibaud Thiollier [France] ; Caisheng Wu [République populaire de Chine] ; Hugues Contamin [France] ; Qin Li [Royaume-Uni] ; Jinlan Zhang [République populaire de Chine] ; Erwan Bezard [France]	Permeability of blood-brain barrier in macaque model of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinson disease.
000033 (2016)	Thibaud Thiollier [France] ; Caisheng Wu ; Hugues Contamin [France] ; Qin Li [Royaume-Uni] ; Jinlan Zhang ; Erwan Bezard [France]	Permeability of blood-brain barrier in macaque model of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson disease.
000036 (2016)	Michel Engeln [France] ; Solène Ansquer [France] ; Emilie Dugast [France] ; Erwan Bezard [France] ; David Belin [Royaume-Uni] ; Pierre-Olivier Fernagut [France]	Multi-facetted impulsivity following nigral degeneration and dopamine replacement therapy.
000050 (2016)	Annalisa Pinna [Italie] ; Wai Kin D. Ko [Royaume-Uni] ; Giulia Costa [Italie] ; Elisabetta Tronci [Italie] ; Camino Fidalgo [Italie] ; Nicola Simola [Italie] ; Qin Li [Royaume-Uni] ; Mojgan Aghazadeh Tabrizi [Italie] ; Erwan Bezard [Royaume-Uni] ; Manolo Carta [Italie] ; Micaela Morelli [Italie]	Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease.
000051 (2016)	Wai Kin D. Ko [Royaume-Uni] ; Sandrine M. Camus [Royaume-Uni] ; Qin Li [Royaume-Uni] ; Jianzhong Yang [Royaume-Uni] ; Steve Mcguire [Royaume-Uni] ; Elsa Y. Pioli [Royaume-Uni] ; Erwan Bezard [France]	An evaluation of istradefylline treatment on Parkinsonian motor and cognitive deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated macaque models.
000052 (2016)	Anna Migdalska-Richards [Royaume-Uni] ; Liam Daly [Royaume-Uni] ; Erwan Bezard [France] ; Anthony H V. Schapira [Royaume-Uni]	Ambroxol effects in glucocerebrosidase and α-synuclein transgenic mice.
000059 (2015)	Sandrine Camus [Royaume-Uni] ; Wai Kin D. Ko [Royaume-Uni] ; Elsa Pioli [Royaume-Uni] ; Erwan Bezard [France]	Why bother using non-human primate models of cognitive disorders in translational research?
000078 (2015)	Mathieu Bourdenx [France] ; Sandra Dovero [France] ; Michel Engeln [France] ; Simone Bido [France] ; Matthieu F. Bastide [France] ; Nathalie Dutheil [France] ; Isabel Vollenweider [Suisse] ; Laetitia Baud [Suisse] ; Camille Piron [France] ; Virginie Grouthier [France] ; Thomas Boraud [France] ; Grégory Porras [Royaume-Uni] ; Qin Li [Royaume-Uni, République populaire de Chine] ; Veerle Baekelandt [Belgique] ; Dieter Scheller [Belgique] ; Anne Michel [Belgique] ; Pierre-Olivier Fernagut [France] ; François Georges [France] ; Grégoire Courtine [Suisse] ; Erwan Bezard [France] ; Benjamin Dehay [France]	Lack of additive role of ageing in nigrostriatal neurodegeneration triggered by α-synuclein overexpression
000103 (2014-07)	Erwan Bezard [France] ; Elsa Y. Pioli [Royaume-Uni] ; Qin Li [Royaume-Uni] ; Françoise Girard [France] ; Vincent Mutel [Suisse] ; Charlotte Keywood [Suisse] ; Francois Tison [France] ; Olivier Rascol [France] ; Sonia M. Poli [Italie]	The mGluR5 negative allosteric modulator dipraglurant reduces dyskinesia in the MPTP macaque model
000104 (2014-04-30)	Wai Kin D. Ko [Royaume-Uni] ; Qin Li [République populaire de Chine] ; Erwan Bezard [France]	Effects of L-tryptophan on L-DOPA-induced dyskinesia in the L-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated macaque model of Parkinson's disease.
000111 (2014)	Anthony H V. Schapira [Royaume-Uni] ; C Warren Olanow [États-Unis] ; J Timothy Greenamyre [États-Unis] ; Erwan Bezard [France]	Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives.
000112 (2014)	Wai Kin D. Ko [France] ; Marie-Laure Martin-Negrier [France] ; Erwan Bezard [France] ; Alan R. Crossman [Royaume-Uni] ; Paula Ravenscroft [Royaume-Uni]	RGS4 is involved in the generation of abnormal involuntary movements in the unilateral 6-OHDA-lesioned rat model of Parkinson's disease.
000124 (2014)	Gregory Porras [France, Royaume-Uni] ; Philippe De Deurwaerdere [France] ; Qin Li [Royaume-Uni, République populaire de Chine] ; Matteo Marti [Italie] ; Rudolf Morgenstern [Allemagne] ; Reinhard Sohr [Allemagne] ; Erwan Bezard [France, Royaume-Uni, République populaire de Chine] ; Michele Morari [Italie] ; Wassilios G. Meissner [France]	L-dopa-induced dyskinesia: beyond an excessive dopamine tone in the striatum
000135 (2014)	Mathieu Bourdenx [France] ; Anna Nilsson [Suède] ; Henrik Wadensten [Suède] ; Maria F Lth [Suède] ; Qin Li [République populaire de Chine] ; Alan R. Crossman [Royaume-Uni] ; Per E. Andrén [Suède] ; Erwan Bezard [République populaire de Chine]	Abnormal structure-specific peptide transmission and processing in a primate model of Parkinson's disease and l-DOPA-induced dyskinesia.
000140 (2014)	Anthony H. V. Schapira [Royaume-Uni] ; C. Warren Olanow [États-Unis] ; J. Timothy Greenamyre [États-Unis] ; Erwan Bezard [France]	Movement disorders 3: Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives
000174 (2013)	Erwan Bezard [France, République populaire de Chine] ; Elisabetta Tronci [Italie, Suède] ; Elsa Y. Pioli [Royaume-Uni] ; Qin Li [République populaire de Chine, Royaume-Uni] ; Gregory Porras [Royaume-Uni] ; Anders Björklund [Suède] ; Manolo Carta [Italie, Suède]	Study of the antidyskinetic effect of eltoprazine in animal models of levodopa‐induced dyskinesia
000183 (2013)	Jay S. Schneider [États-Unis] ; Elsa Y. Pioli [République populaire de Chine, Royaume-Uni] ; Yang Jianzhong [République populaire de Chine, Royaume-Uni] ; Qin Li [République populaire de Chine, Royaume-Uni] ; Erwan Bezard [République populaire de Chine, Royaume-Uni, France]	Levodopa improves motor deficits but can further disrupt cognition in a macaque parkinson model

---

List of associated KwdEn.i

Nombre de documents	Descripteur
10	Animals
7	Disease Models, Animal
7	Parkinson disease
6	Parkinson Disease (drug therapy)
5	Female
4	Animal
4	Antiparkinson Agents (pharmacology)
4	Dyskinesia
4	Humans
4	Levodopa
4	Levodopa (adverse effects)
4	Levodopa (pharmacology)
4	Male
4	Monkey
3	Animal model
3	Corpus Striatum (drug effects)
3	Dopamine (metabolism)
3	Macaca mulatta
3	Nervous system diseases
3	Rats, Sprague-Dawley
3	Treatment
2	Acute
2	Antiparkinson Agents (administration & dosage)
2	Antiparkinson Agents (adverse effects)
2	Antiparkinson agent
2	Autoradiography
2	Corpus Striatum (metabolism)
2	Corpus striatum
2	Dopamine
2	Dopamine Agents (adverse effects)
2	Dyskinesia, Drug-Induced (drug therapy)
2	Enkephalins (metabolism)
2	Levetiracetam
2	Levodopa (administration & dosage)
2	Locus niger
2	Macaca
2	Macaca fascicularis
2	Models
2	Mouse
2	Neuroprotective Agents (therapeutic use)
2	Neurotoxin
2	Parkinson Disease (etiology)
2	Parkinson Disease (metabolism)
2	Parkinson Disease (physiopathology)
2	Parkinsonian Disorders (drug therapy)
2	Primates
2	Protein Precursors (metabolism)
2	Rats
2	Rotigotine
1	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
1	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (adverse effects)
1	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (pharmacology)
1	Abnormal movement
1	Agonist
1	Alzheimer Disease (physiopathology)
1	Amantadine (therapeutic use)
1	Amphetamine
1	Anticonvulsant
1	Antiparkinson Agents (toxicity)
1	Apomorphine (pharmacology)
1	Apoptosis (drug effects)
1	Axon
1	Behavior, Animal (drug effects)
1	Benserazide (adverse effects)
1	Benserazide (pharmacokinetics)
1	Blood-Brain Barrier (drug effects)
1	Brain (drug effects)
1	Brain (physiopathology)
1	Carrier protein
1	Cells, Cultured
1	Chemotherapy
1	Chronic
1	Clinical Trials as Topic (methods)
1	Clinical trial
1	Cognition Disorders (genetics)
1	Cognition Disorders (physiopathology)
1	Combined treatment
1	Corpus Striatum (pathology)
1	Corpus Striatum (physiopathology)
1	D1 Dopamine receptor
1	D2 Dopamine receptor
1	D3 Dopamine receptor
1	Degeneration
1	Development
1	Dopamine Agents (pharmacokinetics)
1	Dopamine Plasma Membrane Transport Proteins (metabolism)
1	Dopamine agonist
1	Drug Combinations
1	Drug Delivery Systems
1	Drug Design
1	Drug Evaluation, Preclinical
1	Drug Therapy, Combination
1	Dyskinesia, Drug-Induced (etiology)
1	Dyskinesia, Drug-Induced (metabolism)
1	Dyskinesia, Drug-Induced (physiopathology)
1	Dyskinesia, Drug-Induced (prevention & control)
1	Dyskinesia, Drug-Induced (therapy)
1	Dyskinesias (etiology)
1	Dyskinesias (metabolism)
1	Encephalon

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/UK/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Author.i -k "Erwan Bezard" 

HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Author.i  \
                -Sk "Erwan Bezard" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/UK/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    UK
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Erwan Bezard
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024